
Linzess (linaclotide capsules) was approved in August 2012 by the FDA as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Linzess (linaclotide capsules) was approved in August 2012 by the FDA as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Women who suffer from celiac disease are more likely to report symptoms of depression and disordered eating, even if they follow a gluten-free diet, researchers have found.

Women with endometriosis are much more likely to develop inflammatory bowel disease than women without the reproductive disorder.

Radiofrequency treatment of patients with refractory gastroesophageal reflux disease appears to improve symptoms by decreasing compliance of the gastroesophageal junction, a new study suggests.

The death toll of the widely publicized listeria outbreak across the United States has risen from 13 to 18.

The FDA has approved Soliris (eculizumab) to treat pediatric and adult patients with atypical hemolytic uremic syndrome.

Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.

The primary endpoints have been met in a clinical trial of a drug for patients suffering from ulcerative colitis.

A researcher has proven that magnetic fields have the potential to act as a blood thinner, and possibly reduce the risk of heart attack.

Irregular periods in teenage girls may be linked to obesity, diabetes, reproductive issues, and heart disease.

The key to managing opioid-induced constipation is early recognition of the problem.

Low vaccination rates among patients with CLD and diabetes have grave public health implications.

Increased risk of clostridium difficile infection may be associated with exposure to linezolid and clindamycin.

Trial of mindfulness training as an intervention for irritable bowel syndrome (IBS) demonstrates substantial therapeutic impact on bowel symptom severity.

Scheduling, session topics, plenary speakers, and other information for physicians planning to attend DDW 2011.

The FDA has received reports that Teva's lansoprazole delayed-release orally disintegrating tablet has clogged and blocked oral syringes and feeding tubes.

Takeda announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors on Plavix

At Pri-Med Southwest, Frank Domino, MD, discussed the dangers of vitamin D deficiency and recommended screening and supplementation for at-risk patients.

John Goodson, MD, opened Pri-Med Southwest 2011 with a keynote address highlighting primary care innovation and advocacy and advice for future success.

Poorly treated GERD has a significant impact on patients' lives and can lead to reduced physical and social activity.

Though 15 percent of passengers contracted acute gastroenteritis, only 60 percent of those affected sought medical care onboard the ship.

Breastfeeding, hand washing, and rotavirus vaccination are some of the low-cost methods researchers say could prevent 5 million diarrheal deaths by 2015.

Data from the North American Pancreatitis Study reveals that more than 50% of CP cases are non-alcohol-related, or have no identifiable cause.

Patients take longer to metabolize alcohol and return to a sober state after gastric bypass, and could have a few too many if they aren't aware.

Long-term use of prescription proton pump inhibitors, or PPIs, can depress serum magnesium levels and, possibly, lead to serious adverse events.